Drug intelligence / Profile preview

autologous bone marrow-derived mesenchymal stem cells (Stem Cells Arabia, f24620)

Development stage
Unknown
Lead developer
Stem Cells Arabia
Modality
Stem Cell Therapies → Cell Therapies
Administration
Intravenous, Intraarticular
01

Overview

This autologous bone marrow-derived mesenchymal stem cell (BM-MSC) therapy is being developed by Stem Cells Arabia for the treatment of rheumatoid arthritis. The treatment involves the extraction of a patient's own bone marrow, followed by the purification and expansion of specific stem cell populations. These cells are then re-administered to the patient via intravenous injection for systemic immunomodulatory effects and direct intra-articular transplantation into affected joints to promote tissue regeneration. The therapy aims to reduce the chronic inflammation of the synovial tissue and repair damage to cartilage, bone, and ligaments characteristic of rheumatoid arthritis. A Phase 1 clinical trial (NCT03067870) was initiated in Jordan to evaluate the safety and efficacy of this regenerative medicine approach.

Other names
BM-MSCsautologous BM-SC

Beyond the preview

Go deeper on autologous bone marrow-derived mesenchymal stem cells (Stem Cells Arabia, f24620).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on autologous bone marrow-derived mesenchymal stem cells (Stem Cells Arabia, f24620).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call